Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 3:43 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 38 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Oxytocin Infusion Clear all

Conditions: Postpartum Hemorrhage
Interventions: Oxytocin Infusion; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Stanford, California

Conditions: Coagulation Changes With Oxytocin
Interventions: Oxytocin; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Dystocia
Interventions: Oxytocin, Sodium Chloride 0.9%; Drug · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 1,003 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Postpartum Hemorrhage
Interventions: Active management of the third stage of labor, Expectant management of the third stage of labor, Oxytocin and gentle cord traction with fundal massage, Oxytocin; Procedure · Drug
Lead sponsor: Christiana Care Health Services; Other
Eligibility: 16 Years and older · Female only
Enrollment: 218 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Osteoarthritis, Knee, Healthy
Interventions: Oxytocin; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 75 Years
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Induced; Birth, Labor Long, Labor Pain, Breast Pumping, Lactation Induced
Interventions: Electronic breast pump, Exogenous oxytocin intravenous infusion; Device · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Prolonged Labor, Failed Induction, Labor Dystocia
Interventions: Oxytocin rest; Other
Lead sponsor: Christiana Care Health Services; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Uterine Atony, Uterine Atony With Hemorrhage, Cesarean Section Complications
Interventions: Calcium Chloride, Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Stanford, California

Conditions: Embryo Transfer
Interventions: Epelsiban, Placebo, Oxytocin, Ortho-Cylcen (21)® tablet; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: Glendale, California • Baltimore, Maryland

Conditions: Postoperative Pain
Interventions: Oxytocin, Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 152 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Premature Rupture of Membranes
Interventions: Foley Catheter, Oxytocin; Device · Drug
Lead sponsor: Geisinger Clinic; Other
Eligibility: Female only
Enrollment: 201 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 5
States / cities: Phoenix, Arizona • Newark, Delaware • Allentown, Pennsylvania + 2 more

Conditions: Uterine Atony, Uterine Atony With Hemorrhage, Postpartum Hemorrhage, Cesarean Section Complications
Interventions: Calcium chloride, Saline placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Pacifica, California

Conditions: Healthy Volunteer Study
Interventions: intravenous oxytocin, intranasal oxytocin; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 75 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Hypermobile Ehlers-Danlos Syndrome, Pain Assessment
Interventions: Oxytocin, Placebo; Drug · Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 64 Years · Female only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Labor Dystocia, Labor Induction, Labor Augmentation
Interventions: Calcium Carbonate 500 MG, Standard Dose Synthetic Pitocin; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Pregnancy
Interventions: Induction of Labor; Procedure
Lead sponsor: Madigan Army Medical Center; Federal
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 162 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2017
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Postpartum Hemorrhage, Uterine Atony
Interventions: 15-methyl prostaglandin F2α, Methylergonovine Maleate; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Oxytocin, Pregnancy
Interventions: Oxytocin; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Post Partum Hemorrhage, Cesarean Section Complications, Blood Loss
Interventions: deuterated oxytocin (d5OT); Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Stanford, California • Chicago, Illinois

Conditions: Osteoarthritis, Knee
Interventions: Oxytocin; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Sunburn
Interventions: oxytocin, placebo; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 55 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Pregnancy, Labor Pain
Interventions: Group A Intravenous bolus of 1000 ml lactated ringers solution, Group B Intravenous bolus bolus 1000 ml lactated ringers solution oxytocin decrease to 1/2 current rate, Group C 125 mL/hr of lactated ringers, Group D 125 mL/hr lactated ringers oxytocin decreased to 1/2 current rate; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 251 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Premature Rupture of Membrane, Unfavorable Cervix
Interventions: Intracervical balloon catheter, Oxytocin; Device · Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 50 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Elective Cesarean Section
Interventions: Oxytocin bolus or oxytocin infusion; Drug
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Stony Brook, New York

Search by objective public record fields.

Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.

The Use of Thromboelastometry (ROTEM) to Evaluate the Changes in Coagulation With Two Different Doses of Oxytocin Following Cesarean Delivery

Comparison of Low-dose and High-dose Oxytocin Regimens for Labor Augmentation

Active Versus Expectant Management of the Third Stage of Labor

Generate a Pharmacodynamic Model of Oxytocin for Peripheral Analgesic Effects

Stimulation Therapy for Inducing Mothers

Oxytocin Rest to Reduce Cesarean Delivery

Calcium Chloride for Prevention of Uterine Atony During Cesarean

A Study to Evaluate Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of Epelsiban

Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy

FOLCROM Trial: Foley Catheter in Rupture of Membranes

Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery

A Pharmacokinetic Study of Intravenous and Intranasal Oxytocin in Healthy Subjects

Oxytocin for Hypermobile Ehlers-Danlos Syndrome

Calcium Carbonate to Augment Labor Contractions

Elective Induction of Nulliparous Labor

Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial

Non-Invasive, Highly Specific Detection of Oxytocin in Biological Fluids

Oxytocin Pharmacokinetics and Pharmacodynamics

Estimate Serum Oxytocin PD Range in the Periphery

A Randomized Controlled Trial to Test the Effects Oxytocin and Vibration Have on Heat Pain Threshold After UV-B Burn

The Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes

Randomized Control Trial of Intracervical Balloon Placement vs Oxytocin in Women With Term PROM and Unripe Cervices

Oxytocin Bolus Versus Infusion in Elective Cesarean Section"